indium in 111 oxyquinoline- indium in-111 oxyquinoline solution
medi-physics inc. dba ge healthcare. - indium in-111 oxyquinoline (unii: lgx9ol562t) (indium cation in-111 - unii:wjz06c0h8l) - indium cation in-111 1 ug in 1 ml - indium in 111 oxyquinoline solution is indicated for radiolabeling autologous leukocytes. indium in 111 oxyquinoline labeled leukocytes may be used as an adjunct in the detection of inflammatory processes to which leukocytes migrate, such as those associated with abscesses or other infection, following reinjection and detection by appropriate imaging procedures. the degree of accuracy may vary with labeling techniques and with the size, location and nature of the inflammatory process. indium in 111 oxyquinoline labeled leukocyte imaging is not the preferred technique for the initial evaluation of patients with a high clinical probability of an abscess in a known location. ultrasound or computed tomography may provide a better anatomical delineation of the infectious process and information may be obtained more quickly than with labeled leukocytes. if localization by these techniques is successful, labeled leukocytes should not be used as a confirmatory procedure. if localization or diagnosis by these methods fails or is ambiguous, indium in 111 oxyquinoline labeled leukocyte imaging may be appropriate. none known.
octreoscan 122mbq/1,1ml prekurzor radiofarmaka
curium netherlands b.v., petten array - 12972 chlorid inditÝ-(111in); 12296 pentetreotid - prekurzor radiofarmaka - 122mbq/1,1ml - indium-(111in) pentetreotid
indium (in-111) oxinat curiumpharma 37 mbq/ml stamlösning till radioaktiva läkemedel
curium netherlands b.v. - indium(in-111)oxinat - stamlösning till radioaktiva läkemedel - 37 mbq/ml - indium(in-111)oxinat 37 mbq aktiv substans - indium(in-111)oxin
indium (111 in) dtpa/mallinckrodt inj.sol 370mbq/10ml vial
mallinckrodt medical b.v. holland westerduinweg 3,, p.o.box 3, 1755, petten, - indium (111 in) pentetate; calcium trisodium pentetate - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 370mbq/10ml vial - indium (111 in) pentetate 37; calcium trisodium pentetate 0,11mg - indium (111in) pentetic acid
indium (111in) dtpa /curium netherlands inj.sol 370mbq/10ml vial
curium netherlands b.v., the netherlands westerduinweg 3,, 1755 petten - indium (111 in) pentetate; calcium trisodium pentetate - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 370mbq/10ml vial - indium (111 in) pentetate 37mbq; calcium trisodium pentetate 0,11mg - indium (111in) pentetic acid
indium dtpa in 111- indium in-111 pentetate disodium solution
medi-physics, inc. dba ge healthcare - indium in-111 pentetate disodium (unii: 7uit3zgc8e) (indium cation in-111 - unii:wjz06c0h8l) - indium cation in-111 1 mci in 1 ml - pentetate indium disodium in 111 is recommended for use in radionuclide cisternography. none known.
indium (in-111) chloride curium 370 mbq/ml précurseur radiopharm. i.v. flac.
curium belgium s.p.r.l.-b.v.b.a. - chlorure d'indium (in-111) 370 mbq/ml - précurseur radiopharmaceutique - 370 mbq/ml - chlorure d'indium (in-111) 370 mbq/ml - indium (111in) compounds
indium (111in) oxinate curium 37 mbq/ml radiofarmac. uitgangsstof i.v. flac.
curium belgium s.p.r.l.-b.v.b.a. - hydroxychinoline 0,025 mg/ml; indium(in-111)oxine 37 mbq/ml - radiofarmaceutische uitgangsstof - 37 mbq/ml - indium(in-111)oxine 37 mbq/ml - indium (111in) oxinate labelled cells
indium (111in) oxinate curium 37 mbq/ml précurseur radiopharm. i.v. flac.
curium belgium s.p.r.l.-b.v.b.a. - hydroxyquinoléine 0,025 mg/ml; oxine d'indium (in-111) 37 mbq/ml - précurseur radiopharmaceutique - 37 mbq/ml - oxine d'indium (in-111) 37 mbq/ml - indium (111in) oxinate labelled cells
indium in-111 oxinate 37 mbq/ml kantaliuos radioaktiivista lääkettä varten
curium netherlands b.v. - indium(111in) oxinate, oxine - kantaliuos radioaktiivista lääkettä varten - 37 mbq/ml - indium(111in)oksinaatti merkatut solut